NIHR Maudsley BRC Blog

Our latest news & events

New funding for innovative neuroimaging research

The NIHR Maudsley BRC has launched two new funding opportunities to support neuroimaging research to investigate the impact of COVID-19 on underrepresented groups and to apply novel analytical methods to existing neuroimaging data.

By NIHR Maudsley BRC at 3 Aug 2021

New research from King's has identified three key inflammatory proteins which are lower in individuals at risk of severe COVID-19.

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, and Weill Cornell Medicine, New York City, has identified three key inflammatory proteins which are lower in individuals at risk of severe COVID-19.

By NIHR Maudsley BRC at 8 Jun 2021

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR King's Clinical Research Facility at 14 Apr 2021

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021

How research on chronic illnesses will improve Long-COVID-19 treatment

A new paper funded by the NIHR Maudsley BRC, published today in Oxford Open Immunology, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.

By NIHR Maudsley BRC at 10 Feb 2021